HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrícia A F Ribeiro Selected Research

Infections

8/2020Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
6/2020Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
1/2020Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.
1/2020A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
11/2019Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice.
2/2019A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
1/2019In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection.
1/2019Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
1/2019High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
1/2019Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrícia A F Ribeiro Research Topics

Disease

18Infections
08/2020 - 07/2017
17Visceral Leishmaniasis (Kala Azar)
08/2020 - 07/2017
13Leishmaniasis
06/2020 - 03/2018
2Neglected Diseases
06/2020 - 01/2020
1Necrosis
01/2019

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
08/2020 - 07/2017
11VaccinesIBA
06/2020 - 07/2017
5Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2020 - 01/2018
4AntigensIBA
01/2019 - 01/2018
3Recombinant ProteinsIBA
06/2020 - 01/2018
3T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
06/2020 - 10/2018
3Interleukin-12 (IL 12)IBA
01/2020 - 10/2018
3Immunoglobulin G (IgG)IBA
01/2020 - 01/2018
3Biomarkers (Surrogate Marker)IBA
11/2019 - 12/2018
3AntibodiesIBA
01/2019 - 06/2018
3Interleukin-10 (Interleukin 10)IBA
01/2019 - 01/2018
3Interleukin-4 (Interleukin 4)IBA
01/2019 - 01/2018
2Liposomes (Liposome)IBA
06/2020 - 11/2018
2Synthetic Vaccines (Recombinant Vaccines)IBA
06/2020 - 01/2020
2ProhibitinsIBA
01/2020 - 01/2018
2NitritesIBA
01/2020 - 01/2018
2DNA VaccinesIBA
11/2019 - 01/2018
2MicellesIBA
02/2019 - 01/2019
2InterferonsIBA
10/2018 - 01/2018
2SaponinsIBA
01/2018 - 07/2017
1Leishmania infantum amastin proteinIBA
01/2020
1Peptide Initiation Factors (Initiation Factor)IBA
01/2020
1ArginaseIBA
11/2019
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1Interleukin-2 (IL2)IBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1ProteomeIBA
01/2019
1NaphthoquinonesIBA
01/2019
1A-Form DNA (A-DNA)IBA
01/2019
1CytokinesIBA
12/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018
1Recombinant Fusion ProteinsIBA
10/2018
1Adenosine Monophosphate (AMP)IBA
03/2018
1Amphotericin B (Amphotericin)FDA LinkGeneric
03/2018
1Virulence Factors (Pathogenicity Factors)IBA
01/2018
1InterleukinsIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Glutamine (L-Glutamine)FDA Link
11/2017
1Phosphopyruvate Hydratase (Enolase)IBA
07/2017

Therapy/Procedure

2Therapeutics
12/2019 - 03/2019